File:Human fetal membrane 01.jpg: Difference between revisions
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
Images on the left side of the panel represent the negative control (IgG/serum) and images on the right side of the panel are sections incubated with specific antibodies/antisera. The tissues used in a–f are human fetal membranes whereas g and h are human endometrium. CB1, CB2 and FAAH Immunoreactivity was observed in the amnion (Am), chorion (Ch) and decidua (Dec) of term fetal membranes, whilst NAPE-PLD immunoreactivity was observed mainly in the endometrial glands (Gl) with sparse staining in endometrial stroma (S). The images are representatives from at least six samples and were taken at 200× magnification. Bar = 50 µm. | Images on the left side of the panel represent the negative control (IgG/serum) and images on the right side of the panel are sections incubated with specific antibodies/antisera. The tissues used in a–f are human fetal membranes whereas g and h are human endometrium. CB1, CB2 and FAAH Immunoreactivity was observed in the amnion (Am), chorion (Ch) and decidua (Dec) of term fetal membranes, whilst NAPE-PLD immunoreactivity was observed mainly in the endometrial glands (Gl) with sparse staining in endometrial stroma (S). The images are representatives from at least six samples and were taken at 200× magnification. Bar = 50 µm. | ||
[[Category:Human]] [[Category:Placenta]] [[Category:Histology]] |
Latest revision as of 18:13, 6 May 2012
Human Fetal Membranes - Cannabinoid Receptor 1
Immunohistochemical staining for Cannabinoid Receptor 1 (CB1) on human term fetal membranes.
- Am - Amnion
- Ch - chorion
- Dec - decidua
Bar = 50 µm
Human fetal membrane 01.jpg
Reference
<pubmed>19238202</pubmed>| PLoS One.
Citation: El-Talatini MR, Taylor AH, Elson JC, Brown L, Davidson AC, et al. (2009) Localisation and Function of the Endocannabinoid System in the Human Ovary. PLoS ONE 4(2): e4579. doi:10.1371/journal.pone.0004579
Copyright: © 2009 El-Talatini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Panel cropped, resized and contrast adjusted from Figure 1. Immunohistochemical staining for CB1, CB2, FAAH and NAPE-PLD on control tissues.
journal.pone.0022548.g001.tif
Images on the left side of the panel represent the negative control (IgG/serum) and images on the right side of the panel are sections incubated with specific antibodies/antisera. The tissues used in a–f are human fetal membranes whereas g and h are human endometrium. CB1, CB2 and FAAH Immunoreactivity was observed in the amnion (Am), chorion (Ch) and decidua (Dec) of term fetal membranes, whilst NAPE-PLD immunoreactivity was observed mainly in the endometrial glands (Gl) with sparse staining in endometrial stroma (S). The images are representatives from at least six samples and were taken at 200× magnification. Bar = 50 µm.
File history
Yi efo/eka'e gwa ebo wo le nyangagi wuncin ye kamina wunga tinya nan
Gwalagizhi | Nyangagi | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 17:57, 6 May 2012 | 726 × 545 (69 KB) | Z8600021 (talk | contribs) | ==Human Fetal Membranes - Cannabinoid Receptor 1== (CB1) Immunohistochemical staining for CB1 human fatal membranes. * Am - Amnion * Ch - chorion * Dec - decidua Bar = 50 µm Human fetal membrane 01.jpg ===Reference=== <pubmed>19238202</pubmed>| [ |
You cannot overwrite this file.
File usage
The following page uses this file: